Search Results - "Buttery, Jim"

Refine Results
  1. 1

    Developing standard safety outcomes for COVID-19 vaccines by Buttery, Jim P.

    Published in Vaccine (21-05-2021)
    “…VAED was first observed following randomised trials of an inactivated respiratory syncytial virus (RSV) vaccine more than 5 decades ago [10–13]. [...]the…”
    Get full text
    Journal Article
  2. 2

    Laboratory-confirmed respiratory viral infection triggers for acute myocardial infarction and stroke: Systematic review protocol by Nguyen, Tu Quan, Vlasenko, Diana, Shetty, Aishwarya N, Reid, Christopher M, Clothier, Hazel J, Buttery, Jim P

    Published in PloS one (10-07-2024)
    “…Cardiovascular disease contributes substantially to global mortality and morbidity. Respiratory tract infections, particularly influenza, may trigger an…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Information systems for vaccine safety surveillance by Buttery, Jim P, Clothier, Hazel

    Published in Human vaccines & immunotherapeutics (30-11-2022)
    “…Immunization implementation in the community relies upon post-licensure vaccine safety surveillance to maintain safe vaccination programs and to detect rare…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Early signal detection of adverse events following influenza vaccination using proportional reporting ratio, Victoria, Australia by Clothier, Hazel J, Lawrie, Jock, Russell, Melissa A, Kelly, Heath, Buttery, Jim P

    Published in PloS one (01-11-2019)
    “…Timely adverse event following immunisation (AEFI) signal event detection is essential to minimise further vaccinees receiving unsafe vaccines. We explored the…”
    Get full text
    Journal Article
  7. 7

    What would have happened anyway? Population data source considerations when estimating background incident rates of adverse events following immunisation to inform vaccine safety by Clothier, Hazel J., Shetty, Aishwarya N., Mesfin, Yonatan, Mackie, Michael, Pearce, Christopher, Buttery, Jim P.

    Published in Vaccine (15-02-2024)
    “…•Understanding background rates helps inform COVID-19, MPox and Shingrix vaccine safety.•Health condition and level of healthcare accessed impact data capture…”
    Get full text
    Journal Article
  8. 8

    A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children by Connell, Tom G, Ritz, Nicole, Paxton, Georgia A, Buttery, Jim P, Curtis, Nigel, Ranganathan, Sarath C

    Published in PloS one (09-07-2008)
    “…There are limited data comparing the performance of the two commercially available interferon gamma (IFN-gamma) release assays (IGRAs) for the diagnosis of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    A Review of Febrile Seizures: Recent Advances in Understanding of Febrile Seizure Pathophysiology and Commonly Implicated Viral Triggers by Sawires, Rana, Buttery, Jim, Fahey, Michael

    Published in Frontiers in pediatrics (13-01-2022)
    “…Febrile seizures are one of the commonest presentations in young children, with a 2-5% incidence in Western countries. Though they are generally benign, with…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Aiming too high: Shoulder injury related to vaccine administration (SIRVA): A case series by Marshall, Tessa, Addison, Mel, Crawford, Nigel W, Buttery, Jim P, Cheng, Daryl R

    Published in Vaccine (12-12-2022)
    “…Shoulder injury directly related to vaccination (SIRVA) occurs when a vaccine is administered too high in the shoulder. The primary aim of this study was to…”
    Get full text
    Journal Article
  14. 14

    Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination – A self-controlled case series analysis by Morgan, Hannah J., Clothier, Hazel J., Sepulveda Kattan, Gonzalo, Boyd, James H., Buttery, Jim P.

    Published in Vaccine (02-04-2024)
    “…•We have identified an association between ChAdOx1 nCoV-19 and an increased risk of Acute Disseminated Encephalomyelitis incident admissions.•Dose-specific…”
    Get full text
    Journal Article
  15. 15

    How Reliable Is a Negative Blood Culture Result? Volume of Blood Submitted for Culture in Routine Practice in a Children's Hospital by Connell, Thomas G, Rele, Mhisti, Cowley, Donna, Buttery, Jim P, Curtis, Nigel

    Published in Pediatrics (Evanston) (01-05-2007)
    “…The primary aims of this study were to determine the volume of blood submitted for culture in routine clinical practice and to establish the proportion of…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Long term follow up and outcomes of Covid-19 vaccine associated myocarditis in Victoria, Australia: A clinical surveillance study by Shenton, Priya, Schrader, Silja, Smith, Julia, Alafaci, Annette, Cox, Nicholas, Taylor, Andrew, Hare, James, Jones, Bryn, Crawford, Nigel W., Buttery, Jim P, Cheng, Daryl R.

    Published in Vaccine (25-01-2024)
    “…•Myocarditis is a well known adverse events of special interest following COVID-19 vaccines.•Limited information has been published regarding medium and longer…”
    Get full text
    Journal Article
  18. 18

    Non-antibiotic medication use in an Indonesian community cohort 0-18 months of age by At Thobari, Jarir, Satria, Cahya Dewi, Ridora, Yohanes, Watts, Emma, Handley, Amanda, Standish, Jane, Bachtiar, Novilia S, Buttery, Jim P, Soenarto, Yati, Bines, Julie E

    Published in PloS one (18-11-2020)
    “…Rational medication use for treatment is mandatory, particularly in children as they are vulnerable to possible hazards of drugs. Understanding the medication…”
    Get full text
    Journal Article
  19. 19

    Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia by Osowicki, Joshua, Morgan, Hannah J., Harris, Adele, Clothier, Hazel J., Buttery, Jim P., Kiers, Lynette, Crawford, Nigel W.

    Published in Vaccine (12-12-2022)
    “…•There have been conflicting reports regarding a temporal association between COVID-19 vaccination and Guillain-Barré Syndrome (GBS).•This case series from…”
    Get full text
    Journal Article
  20. 20

    Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia by Gordon, Sally F., Clothier, Hazel J., Morgan, Hannah, Buttery, Jim P., Phuong, Linny K., Monagle, Paul, Chunilal, Sanjeev, Wood, Erica M., Tran, Huyen, Szer, Jeff, Crawford, Nigel W.

    Published in Vaccine (26-11-2021)
    “…•ITP is known to occur after SARS-CoV-2 infection and measles-mumps-rubella vaccine.•Our data demonstrate an increased risk of ITP following AstraZeneca…”
    Get full text
    Journal Article